Impact of Social Determinants on Triple-Negative Breast Cancer

Dr. Nicholas Robert, CMO of Ontada, discusses new research that examines potential factors that may impact care and outcomes for affected communities with a common and aggressive form of cancer, Triple Negative Breast Cancer. ​​#rwd #sdoh #rwe In his role as Chief Medical Officer, Dr. Robert is responsible for deepening Ontada’s clinical focus and expertise. As the senior clinical leader at Ontada, Dr. Robert collaborates across the organization to ensure studies, real-world data offerings and educational programs maintain the highest scientific standards and clinical relevance. He also collaborates with physicians and physician-led groups, including The US Oncology Network, to support a broad range of clinical initiatives for cancer physicians, nurses, pharmacists, and other care team members.

الفئة